LONDON, September 26, 2016 /PRNewswire/ --
Chemistry Services, Biology Services, Lead Optimisation, Lead Identification and Screening
Where is the drug discovery outsourcing market heading? Visiongain's new report gives you revenue predictions for the drug discovery outsourcing market and its submarkets from 2016 to 2026, helping you stay ahead.
Visiongain's new 232-page report provides revenue forecasts to 2026 for the global drug discovery outsourcing market, four leading submarkets and 13 leading national markets. The report profiles 14 leading CROs providing drug discovery outsourcing, and includes revenue forecasts and analysis to 2026 for 6 of those companies. It also includes 3 interview transcripts with industry experts regarding the current developments and the drivers of growth in the drug discovery outsourcing market.
Besides revenue forecast to 2026, this report provides market shares, business outlooks, qualitative analyses (including SWOT and Porter's Five Forces Analysis), company profiles and commercial partnerships.
See revenue forecasts for leading drug discovery outsourcing sectors
Along with prediction of overall world market value to 2026, our report shows you revenue forecasting for the four services sectors at world level:
• Chemistry services market forecast 2016-2026
• Biology services market forecast 2016-2026
• Lead optimisation market forecast 2016-2026
• Lead identification and screening market forecast 2016-2026
The analysis helps you identify market potential with individual revenue forecasts, annual growth rates and CAGRs and market shares.
Discover prospects of the leading national markets for the drug discovery outsourcing
The drug discovery outsourcing market is becoming increasingly global as companies look to lower costs by off-shoring their work to CROs based in emerging economies.
You will discover individual revenue forecasts, annual growth rates, CAGRs, and market shares to 2026, as well as written supporting analyses for each of the 13 leading national markets and the rest of the world (RoW):
• South Korea
• Rest of the World
Demand for CROs based in emerging markets will be a major driver of growth in this market.
Leading companies and potential for market growth
Our new study predicts the world market for drug discovery outsourcing will reach $19.2bn in 2016. There is the increasing trend for pharmaceutical and biotech companies to form partnerships and alliances with CROs during the early drug discovery phase.
Our research profiles leading companies, assessing their financial performance and products. You will see which organisations hold the greatest potential and what services each offer. See the profiles of 14 leading companies:
• Albany Molecular Research (AMRI)
• Charles River Laboratories
• Pharmaceutical Product Development (PPD)
• Viva Biotech
• WIL Research Laboratories
• WuXi AppTec
To see a report overview please email Sara Peerun on email@example.com
To request a report overview of this report please emails Sara Peerun at firstname.lastname@example.org or call Tel: +44 (0) 20 7336 6100
Organisations and Companies Mentioned
Advion Bioanalytical Labs
Albany Molecular Research (AMRI)
Beijing Genomics Institute
Bio Pontis Alliance
Bristol Myers Squibb
Charles River Laboratories
Great Lakes Chemical Corp
Johnson & Johnson
Laboratory Corporation of America
Midwest Bio Research
Milner Therapeutics Institute and Consortium
Next CODE Health
Pharmaceutical Product Development (PPD)
PhRMA (Pharmaceutical Research and Manufacturers of America)
National Institutes of Health
The Babraham Institute
The Sanger Institute
University of Cambridge
University of Edinburgh
WIL Research Laboratories
SOURCE Visiongain Ltd